|
|
此文章由 wolf123 原创或转贴，不代表本站立场和观点，版权归 oursteps.com.au 和作者 wolf123 所有！转贴必须注明作者、出处和本声明，并保持内容完整
遑论这论文引用到的或者没有引用到的其他论文关于蛋白质如何影响乳糖不耐/肠胃不适症状的研究了，这句话如果你看得明白就该知道哪里去找论文了
下面的话如果看得明白都知道谁写的哪些内容的论文
There are a number of studies on the impact of A1- or A2-milk on digestive tract health [51, 52]. However, the increasing consumption of dairy products is associated with an increase in the risk of gastrointestinal function [53 -56]. Ho et al., [51] have found that A1-milk led to significantly higher stool consistency values (Bristol Stool Scale) compared with the A2-milk. Furthermore the authors found a significant positive association between abdominal pain and stool consistency on the A1-milk diet (r=0.52), but not the A2-milk diet (r=-0.13). Jianqin et al., [57] reported that the consumption of milk containing both types (A1-milk and A2-milk) was associated with significantly greater post-dairy digestive discomfort symptoms; higher concentrations of inflammation-related biomarkers and BCM-7; longer gastrointestinal transit times and lower levels of short-chain fatty acids. On the other hand, consumption of milk containing only A2-milk did not aggravate post-dairy digestive discomfort symptoms. Other studies in Germany have shown that after the application of A2-milk in 10 people who cannot tolerate A1-milk, have not had gastrointestinal problems [7]. He et al. [52] investigated that milk containing A2-milk attenuated acute gastrointestinal symptoms of milk intolerance, while conventional milk containing A1-milk reduced lactase activity and increased gastrointestinal symptoms. Animal studies have shown that the effect of A1- versus A2-milk on gastrointestinal was directly influenced [56, 58]. Similarly, it has been reported that casein and its derivatives, particularly BCM-7, exert a variety of effects on gastrointestinal function in animals, including reducing the frequency and amplitude of intestinal contractions [53, 59-61]. Interestingly, Barnett et al., [ 56] also shown in rats that A1-milk feeding relative to A2-milk feeding significantly increased the colonic activity of the inflammatory marker myeloperoxidase by 65%, an effect also negated by the opioid blocker naloxone. In general, it has been shown that the consumption of milk containing A1-milk would lead to systemic inflammation and gastrointestinal motility through the release of BCM-7 [51, 57]. In fact, further animal research and clinical trials is needed to compare disease risks of A1-free versus ordinary milk、
这是不是饭在嘴边，还要人喂。 |
|
我的一夜附庸风雅 (2005-8-21) 东食西宿 
都柏林 2011年6月 - -- 来自爱尔兰的问候 --- 和三叶草的心动 (2011-6-16) chermside 
楼主:pikachu007
发表于 2022-7-19 12:17
